欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
FI/H/1166/002
药品名称
Ketipinor
活性成分
quetiapine 150.0 mg
剂型
Prolonged-release tablet
上市许可持有人
Orion Corporation Orionintie 1 02200 Espoo Finland
参考成员国 - 产品名称
Finland (FI)
互认成员国 - 产品名称
Lithuania (LT)
Ketipinor 150 mg pailginto atpalaidavimo tabletė
许可日期
2014/11/12
最近更新日期
2024/08/01
药物ATC编码
N05AH04 quetiapine
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final PL
|
EU Ketipinor 50 150 200 300 400mg prolonged release tabl PIL 010721
Date of last change:2024/09/06
Final SPC
|
EU Ketipinor 50 150 200 300 400mg prolonged release tabl SPC 010721
Date of last change:2024/09/06
PubAR
|
Final PAR Ketipinor prolonged release tablets DKH2304_001_005_DC
Date of last change:2024/09/06
PubAR Summary
|
Final sPAR Ketipinor prolonged release tablets DKH2304_001_005_DC
Date of last change:2024/09/06
Final Labelling
|
Ketipinor 50 150 200 300 400mg prolonged_release tabl DCP LABEL 210717
Date of last change:2024/09/06
Final Product Information
|
Ketipinor 50 150 200 300 400mg prolonged_release tabl DCP PIL 230718
Date of last change:2024/09/06
Final Product Information
|
Ketipinor 50 150 200 300 400mg prolonged_release tabl DCP SPC 230718
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase